| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $239.0M | +17.0% |
| Cost of Revenue | $66.7M | +14.2% |
| Gross Profit | $172.3M | +18.1% |
| R&D Expense | $44.5M | +10.5% |
| SG&A Expense | $55.8M | +6.3% |
| Operating Income | -$30.6M | +2.6% |
| Income Tax | -$924K | -588.9% |
| Net Income | -$28.1M | +1.0% |
| EPS (Basic) | -$0.37 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $55.0M | +6.5% |
| Accounts Receivable | $4.3M | +16.1% |
| Current Assets | $105.0M | -13.0% |
| Total Assets | $208.0M | +10.1% |
| Current Liabilities | $84.6M | +10.4% |
| Total Liabilities | $125.6M | +3.0% |
| Stockholders' Equity | $82.4M | +23.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.5M | +24.0% |
| Capital Expenditures | $2.4M | +9.3% |
| Investing Cash Flow | -$6.8M | -177.1% |
| Financing Cash Flow | -$7.3M | +67.0% |
| Free Cash Flow | $15.2M | +26.6% |
| +7.5% |
| EPS (Diluted) | -$0.37 | +7.5% |